Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2003
12/18/2003WO2003104397A2 Antisense modulation of g protein-coupled receptor kinase 6 expression
12/18/2003WO2003104394A2 Nucleic acid molecules encoding a transmembrane serine protease 12, the encoded polypeptides and methods based thereon
12/18/2003WO2003104393A2 Three dimensional vaginal tissue model containing immune cells
12/18/2003WO2003104392A2 Improved reagents and methods for producing parvoviruses
12/18/2003WO2003104385A1 Device for multiple simultaneous gene transfer
12/18/2003WO2003104382A1 Improved method for the prevention or reduction of haze in beverages
12/18/2003WO2003104279A1 Regulation of a human g protein-coupled receptor
12/18/2003WO2003104278A1 Tnf-like protein
12/18/2003WO2003104276A2 Genes and polypeptides relating to hepatocellular or colorectal carcinoma
12/18/2003WO2003104275A2 Genes and polypeptides relating to human colon cancers
12/18/2003WO2003104272A1 Immunogenic compositions
12/18/2003WO2003104271A1 Enzymes which degrade thio compounds, and methods of use thereof
12/18/2003WO2003104258A2 Dominant gene delaying flowering
12/18/2003WO2003104251A2 Composition and methods for obtaining nucleic acids from sputum
12/18/2003WO2003104236A1 Calcitonin gene related peptide receptor antagonists
12/18/2003WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor
12/18/2003WO2003103719A2 Method for triggering apoptosis in cells by increasing the level of c1d and inhibiting the degradation of the same
12/18/2003WO2003103715A1 Modified byrodin 1 with reduced immunogenicity
12/18/2003WO2003103708A1 BIOFUNCTIONAL CpG OR OLIGO-/POLYNUCLEOTIDE AND TOXIN OR ENTEROTOXIN CONTAINING COMPOSITION
12/18/2003WO2003103706A2 Immunogenic compositions
12/18/2003WO2003103608A2 Neuroprotective synergy of erythropoietin and insulin-like growth factor
12/18/2003WO2003103605A2 Flexible vaccine assembly and vaccine delivery platform
12/18/2003WO2003103600A2 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
12/18/2003WO2003103597A2 Methods of diagnosing & treating diabetes and insulin resistance
12/18/2003WO2003103586A2 Method for treating autoimmune or inflammatory diseases with combinations of inhibitory oligonucleotides and small molecule antagonists of immunostimulatory cpg nucleic acids
12/18/2003WO2003103581A2 Compositions and methods for liver growth and liver protection
12/18/2003WO2003103577A2 Novel recombinant anticoagulant proteins
12/18/2003WO2003103571A2 Flavivirus vaccines
12/18/2003WO2003103478A2 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs
12/18/2003WO2003103475A2 Prevention and reduction of blood loss
12/18/2003WO2003103378A2 Fish produced by nuclear transfer from cultured cells
12/18/2003WO2003103377A2 Methods and compositions for production of maize lines with increased transformability
12/18/2003WO2003093436A3 Treatment for phenylketonuria
12/18/2003WO2003085752A3 Molehole embedded 3-d crossbar architecture used in electrochemical molecular memory device
12/18/2003WO2003084981A3 Phage display affinity and specificity filters and forward screen
12/18/2003WO2003082912A3 Transgenic plants expressing mussel adhesive proteins
12/18/2003WO2003080660A3 Method for the preparation of recombinant mammalian heparin-binding protein (hbp)
12/18/2003WO2003078640A3 Recombinant drug-sensitive vaccinia virus as smallpox vaccine
12/18/2003WO2003078445A3 A building block forming a c=c double bond upon reaction
12/18/2003WO2003078050A3 A building block forming a c-c bond upon reaction
12/18/2003WO2003074692A3 Specific gene expression in colonic cancer cell lines
12/18/2003WO2003074558A3 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
12/18/2003WO2003073839A3 Expression of lysosomal enzymes in plant seeds
12/18/2003WO2003070271A3 Novel complexes for inducing an immune response
12/18/2003WO2003068930A3 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
12/18/2003WO2003066847A3 Phytase variants
12/18/2003WO2003060656A3 Simulation of gene expression control using connectrons.
12/18/2003WO2003058248A3 Diagnostics and vaccines for mycrobacterium paratuberculosis infections
12/18/2003WO2003057911A3 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
12/18/2003WO2003057886A3 Detection of mutations
12/18/2003WO2003057849A3 Telomere-encoding synthetic dna nanocircles, and their use for the elongation of telomere repeats
12/18/2003WO2003057843A3 Methods and materials for modulating trpc4
12/18/2003WO2003057159A3 Psoriasin expression by breast epithelial cells
12/18/2003WO2003055977A3 A method for generating overexpression of alleles in genes of unknown function
12/18/2003WO2003054181A3 Nucleic acid labeling by thermoanaerobacter thermohydrosulfuricus dna polymerase i variants
12/18/2003WO2003054160A3 Cell lines with latent immunodeficiency virus and methods of use thereof
12/18/2003WO2003054020A3 Human antibodies against human glycoprotein vi and their use
12/18/2003WO2003052141A9 High troughput analysis and detection of multiple target sequences using circular probes
12/18/2003WO2003052054A3 Bgl5 beta-glucosidase and nucleic acids encoding the same
12/18/2003WO2003051917A3 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/18/2003WO2003048298A3 Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
12/18/2003WO2003046179A3 G-protein coupled receptor lustr2 and uses thereof
12/18/2003WO2003046131A3 Dnmt3l-related cloning and reproductive methods
12/18/2003WO2003044207A3 Method for the preparation of nucleic acids
12/18/2003WO2003044206A3 Process for the preparation of an enantiomerically enriched a-amino acid
12/18/2003WO2003044047A3 Virulence proteins of the genus yersinia and uses thereof
12/18/2003WO2003042405A3 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
12/18/2003WO2003041657A3 Antisense modulation of vitamin d nuclear receptor expression
12/18/2003WO2003040726A3 Screening for hepatitis c virus entry inhibitors
12/18/2003WO2003040687A3 Isolation and purification of nucleic acids
12/18/2003WO2003040373A3 Production of l-lysine by genetically modified corynebacterium glutamicum strains
12/18/2003WO2003040309A3 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
12/18/2003WO2003037164A3 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
12/18/2003WO2003034811A3 Method of improving crop yields
12/18/2003WO2003031608A3 Mutated abl kinase domains
12/18/2003WO2003029437A3 Secreted proteins
12/18/2003WO2003027265A3 Composition and methods for enhancing oligonucleotide-directed nucleic acid sequence alteration
12/18/2003WO2003027244A3 Antisense oligonucleotides and methods to induce tumor cell death
12/18/2003WO2003026389A3 Manipulation of plant polysaccharide synthases
12/18/2003WO2003025163A3 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses
12/18/2003WO2003025149A3 Cell populations which co-express cd49c and cd90
12/18/2003WO2003025146A3 Production of a transgenic avian by cytoplasmic injection
12/18/2003WO2003023057A3 Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
12/18/2003WO2003022040A9 Method for producing transgenic animals
12/18/2003WO2003020896A9 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
12/18/2003WO2003018810A3 Modified cry3a toxins and nucleic acid sequences coding therefor
12/18/2003WO2003018625A3 Allelic variants of herv-k18 provirus and their use in analysis
12/18/2003WO2003016540A3 Humanised baculovirus
12/18/2003WO2003014377A3 Competitive binding assay for identifying inhibitors of hcv polymerase
12/18/2003WO2003014342A3 Identification of a dna variant associated with adult type hypolactasia
12/18/2003WO2003013536A3 Methods for treatment of cancer using irinotecan based on ugt1a1
12/18/2003WO2003013225A3 Wheat plants having increased resistance to imidazolinone herbicides
12/18/2003WO2003008613A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced soda gene
12/18/2003WO2003008606A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced phob or phor gene
12/18/2003WO2003006045A3 Cxcl10 treatment of secondary tissue degeneration
12/18/2003WO2003004684A9 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES
12/18/2003WO2003004679A3 Enoyl-acp reductases
12/18/2003WO2003004598A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
12/18/2003WO2003000916A3 Telomerase expression repressor proteins and methods of using the same
12/18/2003WO2003000903A3 Regulation of human nek-like serine/threonine protein kinase
1 ... 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 ... 4023